CD8A and neoplasm: Human 586mel tumor-specific CD8+ TIL586 cells were adoptively transferred into control or 586mel-bearing NSG mice through intravenous injection using the same procedure used in the naïve T-cell studies (Peng et al, 2005, 2007).